GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GlaxoSmithKline Pharmaceuticals Ltd (BOM:500660) » Definitions » Shiller PE Ratio

GlaxoSmithKline Pharmaceuticals (BOM:500660) Shiller PE Ratio : 66.52 (As of Jun. 08, 2024)


View and export this data going back to 1991. Start your Free Trial

What is GlaxoSmithKline Pharmaceuticals Shiller PE Ratio?

As of today (2024-06-08), GlaxoSmithKline Pharmaceuticals's current share price is ₹2505.10. GlaxoSmithKline Pharmaceuticals's E10 for the fiscal year that ended in Mar24 was ₹37.66. GlaxoSmithKline Pharmaceuticals's Shiller PE Ratio for today is 66.52.

The historical rank and industry rank for GlaxoSmithKline Pharmaceuticals's Shiller PE Ratio or its related term are showing as below:

BOM:500660' s Shiller PE Ratio Range Over the Past 10 Years
Min: 29.11   Med: 40.27   Max: 69.85
Current: 65.67

During the past 13 years, GlaxoSmithKline Pharmaceuticals's highest Shiller PE Ratio was 69.85. The lowest was 29.11. And the median was 40.27.

BOM:500660's Shiller PE Ratio is ranked worse than
88.25% of 536 companies
in the Drug Manufacturers industry
Industry Median: 23.9 vs BOM:500660: 65.67

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

GlaxoSmithKline Pharmaceuticals's adjusted earnings per share data of for the fiscal year that ended in Mar24 was ₹34.830. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ₹37.66 for the trailing ten years ended in Mar24.

Shiller PE for Stocks: The True Measure of Stock Valuation


GlaxoSmithKline Pharmaceuticals Shiller PE Ratio Historical Data

The historical data trend for GlaxoSmithKline Pharmaceuticals's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GlaxoSmithKline Pharmaceuticals Shiller PE Ratio Chart

GlaxoSmithKline Pharmaceuticals Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 37.91 47.67 44.03 35.31 51.60

GlaxoSmithKline Pharmaceuticals Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 35.31 - - - 51.60

Competitive Comparison of GlaxoSmithKline Pharmaceuticals's Shiller PE Ratio

For the Drug Manufacturers - General subindustry, GlaxoSmithKline Pharmaceuticals's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GlaxoSmithKline Pharmaceuticals's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GlaxoSmithKline Pharmaceuticals's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where GlaxoSmithKline Pharmaceuticals's Shiller PE Ratio falls into.



GlaxoSmithKline Pharmaceuticals Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

GlaxoSmithKline Pharmaceuticals's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=2505.10/37.66
=66.52

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GlaxoSmithKline Pharmaceuticals's E10 for the fiscal year that ended in Mar24 is calculated as:

For example, GlaxoSmithKline Pharmaceuticals's adjusted earnings per share data for the fiscal year that ended in Mar24 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar24 (Change)*Current CPI (Mar24)
=34.83/153.0345*153.0345
=34.830

Current CPI (Mar24) = 153.0345.

GlaxoSmithKline Pharmaceuticals Annual Data

Earnings per Share (Diluted) CPI Adj_EPS
201503 0.000 97.163 0.000
201603 22.205 102.518 33.147
201703 19.880 105.196 28.921
201803 20.700 109.786 28.854
201903 26.290 118.202 34.037
202003 5.500 124.705 6.749
202103 21.140 131.771 24.551
202203 100.040 138.822 110.282
202303 36.050 146.865 37.564
202403 34.830 153.035 34.830

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


GlaxoSmithKline Pharmaceuticals  (BOM:500660) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


GlaxoSmithKline Pharmaceuticals Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of GlaxoSmithKline Pharmaceuticals's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


GlaxoSmithKline Pharmaceuticals (BOM:500660) Business Description

Traded in Other Exchanges
Address
Dr. Annie Besant Road, GSK House, Worli, Mumbai, MH, IND, 400 030
GlaxoSmithKline Pharmaceuticals Ltd is an India-based subsidiary of GlaxoSmithKline plc. GSK India develops and manufactures medicines, vaccines, and consumer products. Its medicines portfolio includes prescription drugs for conditions that include asthma, infectious diseases, mental health, and digestion, as well as nonprescription nutrition and cosmetic products. Its vaccines product line includes treatments for conditions such as influenza, HPV, hepatitis, and measles. Its consumer healthcare products include Horlicks-brand packaged food and beverage powders among other retail products. The company derives most of its revenue from India.

GlaxoSmithKline Pharmaceuticals (BOM:500660) Headlines

No Headlines